High Carcinogen Levels Cause More Drug Recalls

High Carcinogen Levels Cause More Drug Recalls

Source: 
RAPS.org
snippet: 

The series of recalls of ranitidine (also known as Zantac) and nizatidine products grew longer with three US Food and Drug Administration (FDA) announcements on Tuesday and Wednesday.

The 150 mg and 300 mg versions of the stomach acid treatment from New Jersey-based generic drugmaker Appco Pharma are being recalled. In addition, Denton Pharma and Northwind Pharmaceuticals also recalled all unexpired lots of ranitidine tablets, 150 mg and 300mg versions. Mylan on Wednesday also recalled three lots of the ulcer treatment nizatidine (including the 150mg and 300mg strengths).